Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population

Molecular Biology Reports

Volumn 39, Issue 9, 2012, Pages 9145-9157

  Jha, Abhimanyu Kumar ^a   Nikbakht, Mohsen ^a   Jain, Veena ^b   Sehgal, Alka ^c   Capalash, Neena ^a   Kaur, Jagdeep ^a  

^a PANJAB UNIVERSITY   (India)

^b Mohan Dai Oswal Cancer Treatment and Research Foundation   (India)

^c GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

AFSI; CpG island; HPV; Hypermethylation; MSP

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; P21 GENE; P27 GENE; P53 GENE; P57 GENE; P73 GENE; PAPILLOMAVIRUS INFECTION; PASSIVE SMOKING; POPULATION RESEARCH; PROMOTER REGION; RB 1 GENE; SEXUAL INTERCOURSE; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

BASE SEQUENCE; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RETINOBLASTOMA PROTEIN; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84865154085     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1787-5     Document Type: Article

References (62)

1. Globocan (2008) http://www.dep.iarc.fr/globocan/database.htm. Accessed 13 Nov 2010
2. Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1-17 (Pubitemid 36114705)
3. Malumbres M, Barbacid M (2001) To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1:222-231 (Pubitemid 33741897)
4. Hunter T (1993) Braking the cell cycle. Cell 75:839-841 (Pubitemid 24014541)
5. Hirama T, Koeffer HP (1995) Role of the cyclin dependent kinase inhibitors in the development of cancer. Blood 86:841-854
6. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174 (Pubitemid 24108052)
7. WAF1. Cancer Res 55:4536-4539
8. CIP1/WAF1 proteins following g-irradiation of human lymphoma cells. Cancer Res 55:2387-2393
9. WAF1/CIP1 in human immature leukemic cells. Eur J Haematol 65:221-236
10. WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst 90:1072-1079 (Pubitemid 28350272)
11. WAF1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 89:272-278
12. WAF1/CIP1 gene. Exp Cell Res 246:280-289 (Pubitemid 29393989)
13. Shiohara M, el-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84:3781-3784 (Pubitemid 24362476)
14. WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas. Blood 103:743-746 (Pubitemid 38140115)
15. KIP1 promoter methylation in malignant melanoma. Oncogene 9:5111-5115
16. KIP2 gene at 11p15.5. Oncogene 12:1365-1368
17. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878 (Pubitemid 24289415)
18. Hussain SP, Hofseth LJ, Harris CC (2001) Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. Lung Cancer 34(Suppl 2):S7-S15 (Pubitemid 33103766)
19. Cho Y, Gorina S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355 (Pubitemid 24259959)
20. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819 (Pubitemid 27357971)
21. Zhu J, Jiang J, Zhou W, Chen X (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 58:5061-5065 (Pubitemid 28521161)
22. Melino G, Laurenzi VD, Vousden KH (2002) p73: friend or foe in tumorigenesis. Nat Rev Cancer 2:605-615 (Pubitemid 37328927)
23. Knudson AG (1978) Retinoblastoma: a prototypic hereditary neoplasm. Semin Oncol 5:57-60
24. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646 (Pubitemid 16008560)
25. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677 (Pubitemid 26414890)
26. González AD, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E (2005) Epigenetics of cervical cancer. An overview and therapeutic perspective. Mol Cancer 4:38 (Pubitemid 41631192)
27. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF (2001) Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 7:584-589 (Pubitemid 32707982)
28. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229 (Pubitemid 32695003)
29. Kang S, Bader AG, Vogt PK (2005) Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 102(3):802-807 (Pubitemid 40282746)
30. Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D (2004) Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res 64:5511-5517 (Pubitemid 39006576)
31. D'Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta RA (1998) Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34:413-420 (Pubitemid 28440307)
32. Park JS, Dong SM, Kim HS, Lee JY, Jong US, Park IS, Kim SJ, Namkoong SE (1999) Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett 136:101-108 (Pubitemid 29142308)
33. INK4b. Cancer Res 56:722-727
34. Go JH (2003) Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas. Mod Pathol 16:752-755 (Pubitemid 37011069)
35. Chim CS, Fung TK, Wong KF, Lau JS, Law M, Liang R (2006) Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J Clin Pathol 59(9):921-926 (Pubitemid 44422844)
36. Chim CS, Liang R, Fung TK, Kwong YL (2005) Infrequent epigenetic dysregulation of CIP/KIP family of cyclin-dependent kinase inhibitors in multiple myeloma. Leukemia 19:2352-2355 (Pubitemid 41741639)
37. Yeh KT, Chang GA, Lin TH, Wang YF, Tien N, Chang JY, Chen CJ, Shih MC (2003) Epigenetics changes of tumor suppressor genes, p15, p16, VHIL and p53 in oral cancer. Oncol Rep 10:659-663
38. Siu LL, Chan JK, Wong KF, Kwong YL (2002) Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol 160:59-66 (Pubitemid 34052266)
39. Dong SM, Lee EJ, Jeon SE, Park CK, Kim KM (2005) Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol 18:170-178 (Pubitemid 40188623)
40. Jha AK, Kumar S, Nikbakht M, Sharma V, Kaur J (2011) Epigenetics and its role in ageing and cancer. J Med Med Sci 2(3):696-713
41. Jha AK, Nikbakht M, Capalash N, Kaur J (2010) DNA methylation inhibitors: role in cancer therapy. SAJOSPS 11(1):131
42. Jha AK, Nikbakht M, Parashar G, Shrivastava A, Capalash N, Kaur J (2010) Reversal of hypermethylation and reactivation of the RARβ2 gene by natural compounds in cervical cancer lines. Folia Biol (Praha) 56:195-200
43. CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia. Blood 99:2291-2296 (Pubitemid 34525411)
44. CIP1 DNA methylation in acute lymphocytic leukemia. Blood 100:3432-3433
45. Hui AM, Sun L, Kanai Y, Sakamoto M, Hirohashi S (1998) Reduced p27KIP1 expression in hepatocellular carcinomas. Cancer Lett 132:67-73 (Pubitemid 28535186)
46. Ito C, Kumagai M, Manabe A et al (1999) Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood 93:315
47. KIP1 gene in the hepatocellular carcinoma. Cancer Lett 153:169-173 (Pubitemid 30209859)
48. ARF is a key alteration for progression of oral squamous cell carcinoma. Oral Oncol 41:614-622 (Pubitemid 40828879)
49. Takashi O, Takao W, Yoichi K, Atsuo Y, Kazunari Y, Akiyoshi O, Chiaki K, Takao K (2006) Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas. Oncol Rep 16:957-963
50. KIP1 expression in rodent pituitary cell lines. Am J Pathol 153:1475-1482 (Pubitemid 28509904)
51. INK4a genes in primary central nervous system lymphomas. Cancer Res 61:6335-6339 (Pubitemid 32783233)
52. Moreira PR (2009) Methylation of p16, p21, p27, RB1 and p53 genes in odontogenic keratocysts. J Oral Pathol Med 38(1):99-103
53. KIP1 in prostate carcinoma. Prostate 48:248-253 (Pubitemid 32816550)
54. Nakatsuka S, Liu A, Yao M, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, Aozasa K (2003) Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies. Int J Oncol 22:561-568
55. KIP2 are involved in the development and progression of gastric MALT lymphomas. Mod Pathol 19:141-148 (Pubitemid 43250989)
56. Kang HJ, Kim SJ, Noh DY, Park IA, Choe KJ, Yoo OJ, Kang HS (2001) Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Investig 81:573-579 (Pubitemid 32298803)
57. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG (1999) Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 59:3352-3356 (Pubitemid 29334490)
58. Zheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, Leung K, Buffler PA, Wiencke JK (2004) Hypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res 64:2000-2006 (Pubitemid 38339446)
59. ARF tumor suppressor pathway in lowgrade diffuse astrocytomas and its influence on clinical course. Clin Cancer Res 9:4884-4890 (Pubitemid 37323294)
60. Liu SS, Leung RC, Chan KY, Chiu PM, Cheung AN, Tam KF, Ng TY, Wong LC, Ngan HY (2004) p73 Expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 10:3309-3316 (Pubitemid 38685435)
61. Malekzadeh K, Sobti RC, Nikbakht M, Shekari M, Hosseini SA, Tamandani DK, Singh SK (2009) Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer. Cancer Investig 27(1):70-80
62. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2:24 (Pubitemid 38751473)